Figure 1 — A SARS-CoV-2 related signature that explores the tumor microenvironment and predicts immunotherapy response in esophageal squamous cell cancer

Navigate

Research Paper|Volume 15, Issue 19|pp. 10501–10523

A SARS-CoV-2 related signature that explores the tumor microenvironment and predicts immunotherapy response in esophageal squamous cell cancer

Back to articleFigure 1(1 of 11)

100%

Figure 1.The flow chart of this study.

Figure 1 — A SARS-CoV-2 related signature that explores the tumor microenvironment and predicts immunotherapy response in esophageal squamous cell cancer | Aging